Sophia Genetics Announces First Deal With Britain’s NHS and Leading Turkish Laboratory, Expanding European Customer Base

Sophia Genetics, the European leader in Data Driven Medicine, has significantly expanded its European customer base through its first deal with the NHS in the United Kingdom and an agreement with a leading Turkish laboratory. This follows a surge in demand for the company’s Clinical Genomics offerings among laboratories and hospitals in Germany, France and Italy, with additional customer relationships in these countries established in August.

Please to read the entire article.